Tavneos Drug for Autoimmune Diseases Withdrawn from French Market After Overseas Deaths

France's national drug agency has withdrawn Tavneos from the market due to safety concerns. The drug, used for rare autoimmune and inflammatory diseases, is prescribed to 600 people in France. The decision follows reports of several deaths abroad.